{"schema_version":"secwatch.filing_event.v1","accession":"0001477449-24-000017","form_type":"8-K","ticker":"TDOC","cik":"0001477449","company_name":"Teladoc Health, Inc.","filed_at":"2024-02-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.287554+00:00","generated_at":"2026-06-05T23:01:00.423754+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Teladoc Q4 2023 revenue $660.5M, adj. EBITDA up 22% to $114.4M; guides FY2024 revenue $2.64-2.74B","bullets":["Q4 revenue $660.5M (+4% YoY); Full year revenue $2,602.4M (+8% YoY).","Q4 net loss $28.9M ($0.17/sh) vs $3.81B loss a year ago; FY net loss $220.4M ($1.34/sh).","Q4 adjusted EBITDA $114.4M (+22% YoY); FY adj. EBITDA $328.1M (+33% YoY); FY free cash flow $193.7M.","FY2024 guidance: revenue $2,635-2,735M, adj. EBITDA $350-390M, free cash flow $210-240M.","Efficiency program targets ~$43M net expense reduction in 2024; expects $85M annualized savings."],"urls":{"canonical":"https://secwatch.observer/filing/0001477449-24-000017","json":"https://secwatch.observer/filing/0001477449-24-000017.json","markdown":"https://secwatch.observer/filing/0001477449-24-000017.md","text":"https://secwatch.observer/filing/0001477449-24-000017.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1477449/000147744924000017/0001477449-24-000017-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1477449/000147744924000017/tdoc-20240220.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T23:01:00.423754+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"380bb0cd26fee3e3b071b7f1746ea3e619ba2e77","claim":"Teladoc Health, Inc. reported the full year ended December 31, 2023 results: revenue $2,602.4 million, net income $220.4 million, EPS $1.34 per share. Guidance initiated.","evidence_excerpt":"Teladoc Health Reports Fourth Quarter and Full Year 2023 Results • Fourth quarter 2023 revenue increase of 4% and full year 2023 revenue increase of 8% to $2,602.4 million • Fourth quarter 2023 net loss of $28.9 million, or $0.17 per share, and full year 2023 net loss of $220.4 million, or $1.34 per share","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1477449/000147744924000017/0001477449-24-000017-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the full year ended December 31, 2023"},{"label":"Revenue","value":"$2,602.4 million"},{"label":"Net income","value":"$220.4 million"},{"label":"EPS","value":"$1.34 per share"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"779c836f266b5058b20af963efb515d6963f4252","claim":"Teladoc Health, Inc. reported the fourth quarter of 2023 results: revenue $660.5 million, net income $28.9 million, EPS $0.17 per share. Guidance initiated.","evidence_excerpt":"$ (84.60) 98 % Adjusted EBITDA (1) $ 114,443 $ 94,094 22 % $ 328,120 $ 246,513 33 % See note (1) in the Notes section that follows. 1 Fourth Quarter 2023 Revenue increased 4% to $660.5 million from $637.7 million in the fourth quarter of 2022. Access fees revenue grew 4% to $573.9 million and other revenue grew 3% to $86.6 million. U.S. revenue grew 2% to $564.8","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1477449/000147744924000017/0001477449-24-000017-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter of 2023"},{"label":"Revenue","value":"$660.5 million"},{"label":"Net income","value":"$28.9 million"},{"label":"EPS","value":"$0.17 per share"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}